{"id":1331,"date":"2019-09-09T12:45:02","date_gmt":"2019-09-09T12:45:02","guid":{"rendered":"https:\/\/blogs.bmj.com\/jmg\/?p=1331"},"modified":"2026-02-24T00:29:20","modified_gmt":"2026-02-24T00:29:20","slug":"homozygous-damaging-sod2-variant-causes-lethal-neonatal-dilated-cardiomyopathy","status":"publish","type":"post","link":"https:\/\/blogs.bmj.com\/jmg\/2019\/09\/09\/homozygous-damaging-sod2-variant-causes-lethal-neonatal-dilated-cardiomyopathy\/","title":{"rendered":"Homozygous damaging SOD2 variant causes lethal neonatal dilated cardiomyopathy (Contributed by Dr. Johanna Herkert)"},"content":{"rendered":"<p>Cardiomyopathy, or a deterioration of the ability of the heart muscle to contract, generally leads to progressive heart failure. It is frequently inherited, and, because approximately 40% of affected children are likely to die within five years of diagnosis, being able to identify its genetic basis is particularly important. Now, we have identified a new disease gene,\u00a0<em>superoxide dismutase 2<\/em>\u00a0(<em>SOD2<\/em>) which is implicated in the development of severe paediatric cardiomyopathy. SOD2 is an enzyme that scavenges oxygen radicals that are produced during normal energy metabolism of the cells. The SOD2 variant was shown to affect the catalytic activity of the protein, leading to excess oxygen radical levels that can have strongly damaging effects in the neonatal heart. Our findings offer new clues for future studies into the pathogenesis of cardiomyopathy and may contribute to the development of gene-tailored management strategies. (<a href=\"https:\/\/jmg.bmj.com\/content\/early\/2019\/09\/06\/jmedgenet-2019-106330\">https:\/\/jmg.bmj.com\/content\/early\/2019\/09\/06\/jmedgenet-2019-106330<\/a> )<!--TrendMD v2.4.8--><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Cardiomyopathy, or a deterioration of the ability of the heart muscle to contract, generally leads to progressive heart failure. It is frequently inherited, and, because approximately 40% of affected children are likely to die within five years of diagnosis, being able to identify its genetic basis is particularly important. Now, we have identified a new [&#8230;]<\/p>\n<p><a class=\"btn btn-secondary understrap-read-more-link\" href=\"https:\/\/blogs.bmj.com\/jmg\/2019\/09\/09\/homozygous-damaging-sod2-variant-causes-lethal-neonatal-dilated-cardiomyopathy\/\">Read More&#8230;<\/a><\/p>\n","protected":false},"author":123,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-1331","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Homozygous damaging SOD2 variant causes lethal neonatal dilated cardiomyopathy (Contributed by Dr. Johanna Herkert) - JMG Contact blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/blogs.bmj.com\/jmg\/2019\/09\/09\/homozygous-damaging-sod2-variant-causes-lethal-neonatal-dilated-cardiomyopathy\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Homozygous damaging SOD2 variant causes lethal neonatal dilated cardiomyopathy (Contributed by Dr. Johanna Herkert) - JMG Contact blog\" \/>\n<meta property=\"og:description\" content=\"Cardiomyopathy, or a deterioration of the ability of the heart muscle to contract, generally leads to progressive heart failure. It is frequently inherited, and, because approximately 40% of affected children are likely to die within five years of diagnosis, being able to identify its genetic basis is particularly important. Now, we have identified a new [...]Read More...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/blogs.bmj.com\/jmg\/2019\/09\/09\/homozygous-damaging-sod2-variant-causes-lethal-neonatal-dilated-cardiomyopathy\/\" \/>\n<meta property=\"og:site_name\" content=\"JMG Contact blog\" \/>\n<meta property=\"article:published_time\" content=\"2019-09-09T12:45:02+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-24T00:29:20+00:00\" \/>\n<meta name=\"author\" content=\"hqqu\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@HuiQiQu\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"hqqu\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2019\\\/09\\\/09\\\/homozygous-damaging-sod2-variant-causes-lethal-neonatal-dilated-cardiomyopathy\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2019\\\/09\\\/09\\\/homozygous-damaging-sod2-variant-causes-lethal-neonatal-dilated-cardiomyopathy\\\/\"},\"author\":{\"name\":\"hqqu\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/person\\\/be0250f8d5b52412c3e7c222dabd591b\"},\"headline\":\"Homozygous damaging SOD2 variant causes lethal neonatal dilated cardiomyopathy (Contributed by Dr. Johanna Herkert)\",\"datePublished\":\"2019-09-09T12:45:02+00:00\",\"dateModified\":\"2026-02-24T00:29:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2019\\\/09\\\/09\\\/homozygous-damaging-sod2-variant-causes-lethal-neonatal-dilated-cardiomyopathy\\\/\"},\"wordCount\":161,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#organization\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2019\\\/09\\\/09\\\/homozygous-damaging-sod2-variant-causes-lethal-neonatal-dilated-cardiomyopathy\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2019\\\/09\\\/09\\\/homozygous-damaging-sod2-variant-causes-lethal-neonatal-dilated-cardiomyopathy\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2019\\\/09\\\/09\\\/homozygous-damaging-sod2-variant-causes-lethal-neonatal-dilated-cardiomyopathy\\\/\",\"name\":\"Homozygous damaging SOD2 variant causes lethal neonatal dilated cardiomyopathy (Contributed by Dr. Johanna Herkert) - JMG Contact blog\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#website\"},\"datePublished\":\"2019-09-09T12:45:02+00:00\",\"dateModified\":\"2026-02-24T00:29:20+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2019\\\/09\\\/09\\\/homozygous-damaging-sod2-variant-causes-lethal-neonatal-dilated-cardiomyopathy\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2019\\\/09\\\/09\\\/homozygous-damaging-sod2-variant-causes-lethal-neonatal-dilated-cardiomyopathy\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2019\\\/09\\\/09\\\/homozygous-damaging-sod2-variant-causes-lethal-neonatal-dilated-cardiomyopathy\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Homozygous damaging SOD2 variant causes lethal neonatal dilated cardiomyopathy (Contributed by Dr. Johanna Herkert)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#website\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/\",\"name\":\"JMG Contact blog\",\"description\":\"JMG Contact blog\",\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#organization\",\"name\":\"JMG Contact blog\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/files\\\/2017\\\/10\\\/blog-logo-jmg.png\",\"contentUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/files\\\/2017\\\/10\\\/blog-logo-jmg.png\",\"width\":300,\"height\":34,\"caption\":\"JMG Contact blog\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/person\\\/be0250f8d5b52412c3e7c222dabd591b\",\"name\":\"hqqu\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g\",\"caption\":\"hqqu\"},\"description\":\"Huiqi Qu has a background as a physician trained in internal medicine and a PhD in Experimental Medicine (Endocrinology). His research applies human genetics and multi-omics to complex and pediatric diseases, including GWAS, polygenic risk scores (PRS), single-cell transcriptomics, and integrative genomics to support precision medicine and clinical translation.\",\"sameAs\":[\"https:\\\/\\\/x.com\\\/HuiQiQu\"],\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/author\\\/hqiqu\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Homozygous damaging SOD2 variant causes lethal neonatal dilated cardiomyopathy (Contributed by Dr. Johanna Herkert) - JMG Contact blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/blogs.bmj.com\/jmg\/2019\/09\/09\/homozygous-damaging-sod2-variant-causes-lethal-neonatal-dilated-cardiomyopathy\/","og_locale":"en_US","og_type":"article","og_title":"Homozygous damaging SOD2 variant causes lethal neonatal dilated cardiomyopathy (Contributed by Dr. Johanna Herkert) - JMG Contact blog","og_description":"Cardiomyopathy, or a deterioration of the ability of the heart muscle to contract, generally leads to progressive heart failure. It is frequently inherited, and, because approximately 40% of affected children are likely to die within five years of diagnosis, being able to identify its genetic basis is particularly important. Now, we have identified a new [...]Read More...","og_url":"https:\/\/blogs.bmj.com\/jmg\/2019\/09\/09\/homozygous-damaging-sod2-variant-causes-lethal-neonatal-dilated-cardiomyopathy\/","og_site_name":"JMG Contact blog","article_published_time":"2019-09-09T12:45:02+00:00","article_modified_time":"2026-02-24T00:29:20+00:00","author":"hqqu","twitter_card":"summary_large_image","twitter_creator":"@HuiQiQu","twitter_misc":{"Written by":"hqqu","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/blogs.bmj.com\/jmg\/2019\/09\/09\/homozygous-damaging-sod2-variant-causes-lethal-neonatal-dilated-cardiomyopathy\/#article","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2019\/09\/09\/homozygous-damaging-sod2-variant-causes-lethal-neonatal-dilated-cardiomyopathy\/"},"author":{"name":"hqqu","@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/person\/be0250f8d5b52412c3e7c222dabd591b"},"headline":"Homozygous damaging SOD2 variant causes lethal neonatal dilated cardiomyopathy (Contributed by Dr. Johanna Herkert)","datePublished":"2019-09-09T12:45:02+00:00","dateModified":"2026-02-24T00:29:20+00:00","mainEntityOfPage":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2019\/09\/09\/homozygous-damaging-sod2-variant-causes-lethal-neonatal-dilated-cardiomyopathy\/"},"wordCount":161,"commentCount":0,"publisher":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#organization"},"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/blogs.bmj.com\/jmg\/2019\/09\/09\/homozygous-damaging-sod2-variant-causes-lethal-neonatal-dilated-cardiomyopathy\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/blogs.bmj.com\/jmg\/2019\/09\/09\/homozygous-damaging-sod2-variant-causes-lethal-neonatal-dilated-cardiomyopathy\/","url":"https:\/\/blogs.bmj.com\/jmg\/2019\/09\/09\/homozygous-damaging-sod2-variant-causes-lethal-neonatal-dilated-cardiomyopathy\/","name":"Homozygous damaging SOD2 variant causes lethal neonatal dilated cardiomyopathy (Contributed by Dr. Johanna Herkert) - JMG Contact blog","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#website"},"datePublished":"2019-09-09T12:45:02+00:00","dateModified":"2026-02-24T00:29:20+00:00","breadcrumb":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2019\/09\/09\/homozygous-damaging-sod2-variant-causes-lethal-neonatal-dilated-cardiomyopathy\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/blogs.bmj.com\/jmg\/2019\/09\/09\/homozygous-damaging-sod2-variant-causes-lethal-neonatal-dilated-cardiomyopathy\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/blogs.bmj.com\/jmg\/2019\/09\/09\/homozygous-damaging-sod2-variant-causes-lethal-neonatal-dilated-cardiomyopathy\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/blogs.bmj.com\/jmg\/"},{"@type":"ListItem","position":2,"name":"Homozygous damaging SOD2 variant causes lethal neonatal dilated cardiomyopathy (Contributed by Dr. Johanna Herkert)"}]},{"@type":"WebSite","@id":"https:\/\/blogs.bmj.com\/jmg\/#website","url":"https:\/\/blogs.bmj.com\/jmg\/","name":"JMG Contact blog","description":"JMG Contact blog","publisher":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/blogs.bmj.com\/jmg\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/blogs.bmj.com\/jmg\/#organization","name":"JMG Contact blog","url":"https:\/\/blogs.bmj.com\/jmg\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/logo\/image\/","url":"https:\/\/blogs.bmj.com\/jmg\/files\/2017\/10\/blog-logo-jmg.png","contentUrl":"https:\/\/blogs.bmj.com\/jmg\/files\/2017\/10\/blog-logo-jmg.png","width":300,"height":34,"caption":"JMG Contact blog"},"image":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/person\/be0250f8d5b52412c3e7c222dabd591b","name":"hqqu","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g","caption":"hqqu"},"description":"Huiqi Qu has a background as a physician trained in internal medicine and a PhD in Experimental Medicine (Endocrinology). His research applies human genetics and multi-omics to complex and pediatric diseases, including GWAS, polygenic risk scores (PRS), single-cell transcriptomics, and integrative genomics to support precision medicine and clinical translation.","sameAs":["https:\/\/x.com\/HuiQiQu"],"url":"https:\/\/blogs.bmj.com\/jmg\/author\/hqiqu\/"}]}},"_links":{"self":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts\/1331","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/users\/123"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/comments?post=1331"}],"version-history":[{"count":0,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts\/1331\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/media?parent=1331"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/categories?post=1331"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/tags?post=1331"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}